XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Earning (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share

The earnings (loss) per share accounting guidance is discussed in Note 1. Diluted loss per share excludes all dilutive potential shares if their effect is anti-dilutive. The following table sets forth the computation of the Company’s basic and diluted net earnings (loss) per share available to common stockholders (unaudited) for the three and nine months ended September 30, 2023 and 2022:

   2023   2022   2023   2022 
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
Numerator                
Net income (loss) from continuing operations  $(547,113)  $(1,339,865)  $1,544,377   $(4,105,838)
Deemed dividends   -    -    -    (330,876,369)
Net income (loss) available to common stockholders, continuing operations   (547,113)   (1,339,865)   1,544,377    (334,982,207)
Net loss from discontinued operations   (1,116)   (1,696)   (9,213)   (7,075)
Net income (loss) available to common stockholders  $(548,229)  $(1,341,561)  $1,535,164   $(334,989,282)
                     
Denominator                    
Weighted average number of shares of common stock outstanding during the period - basic   31,401,420,083    10,569,572,256    30,369,571,341    4,130,876,898 
Warrants   -    -    20,977,778,506    - 
Convertible preferred stock   -    -    451,710,162,027    - 
Weighted average number of shares of common stock outstanding during the period - diluted   31,401,420,083    10,569,572,256    503,057,511,874    4,130,876,898 
Net income (loss) per share of common stock available to common stockholders - basic:                    
Continuing operations  $(0.00)  $(0.00)  $0.00   $(0.08)
Discontinued operations   (0.00)   (0.00)   (0.00)   (0.00)
Total basic  $(0.00)  $(0.00)  $0.00   $(0.08)
                     
Net income (loss) per share of common stock available to common stockholders - diluted:                    
Continuing operations  $(0.00)  $(0.00)  $0.00   $(0.08)
Discontinued operations   (0.00)   (0.00)   (0.00)   (0.00)
Total diluted  $(0.00)  $(0.00)  $0.00   $(0.08)
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

   2023   2022 
   Three Months September 30, 
   2023   2022 
Warrants   511,333,351,089    511,333,351,092 
Convertible preferred stock   444,750,633,333    466,707,633,333 
Convertible debentures   28,777,833,333    28,777,833,333 
Stock options   26    26 
Anti-dilutive shares   984,861,817,781    1,006,818,817,784 

 

For the nine months ended September 30, 2023 and 2022, the following potential common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:

 

   2023   2022 
   Nine Months September 30, 
   2023   2022 
Warrants   490,355,572,583    511,333,351,092 
Convertible preferred stock   -    466,707,633,333 
Convertible debentures   28,777,833,333    28,777,833,333 
Stock options   26    26 
Anti-dilutive shares   519,133,405,942    1,006,818,817,784